E. Horst

Accelerated radiochemotherapy in pancreatic cancer is not necessarily related to a pathologic pancreatic function decline in the early period.

N. Willich, C. Rübe, M. Seidel, 2002, International journal of radiation oncology, biology, physics.

CA 19-9 in the therapy monitoring and follow-up of locally advanced cancer of the exocrine pancreas treated with radiochemotherapy.

N. Willich, O. Micke, E. Horst, 2003, Anticancer research.

CT Simulation in Nodal Positive Breast Cancer

N. Willich, A. Schuck, C. Moustakis, 2001, Strahlentherapie und Onkologie.

Functional evaluation of the human pancreas before and in the early period after hyperfractionated accelerated radiochemotherapy.

N. Willich, C. Rübe, M. Seidel, 2002, Frontiers of radiation therapy and oncology.

Results and follow-up of locally advanced cancer of the exocrine pancreas treated with radiochemotherapy.

N. Willich, O. Micke, A. Devries, 2005, Anticancer research.

Predictive value of carbohydrate antigen 19-9 in pancreatic cancer treated with radiochemotherapy.

N. Willich, O. Micke, A. Devries, 2003, International journal of radiation oncology, biology, physics.

Radiation therapy approach in gliomatosis cerebri--case reports and literature review.

N. Willich, C. Rübe, W. Paulus, 2000, Acta oncologica.

The clinical value of squamous cell carcinoma antigen in patients irradiated for locally advanced cancer of the head and neck.

N. Willich, O. Micke, E. Horst, 2003, Anticancer Research.

Conformal therapy for pancreatic cancer: variation of organ position due to gastrointestinal distention--implications for treatment planning.

N. Willich, A. Schuck, C. Moustakis, 2002, Radiology.